Tapewire

Nasdaq · USD

GH

Guardant Health, Inc.

Export transactions ↓
Tapewire entity
3238
SEC CIK
0001576280
Parsed reports
867

Last 12 months

Inside the activity.

1 purchase rows · 142 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 2025048
Jan 202606
Feb 202600
Mar 202606
Apr 202602
May 2026024
Jun 2026126
Jul 202601
Aug 2026017
Sep 202608
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 17, 2025 Filed Nov 18, 2025 22:07 UTC Exercise / conversionRestricted Stock Units · Derivative 232 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001865525-25-000013 · wk-form4_1763503670.xml · derivative · entry 2

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,425

Underlying: Common Stock · 232 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 22:07 UTC Exercise / conversionCommon Stock 232 $0.00 $0.00
Disclosure

SEC source: 0001865525-25-000013 · wk-form4_1763503670.xml · nonDerivative · entry 1

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2025 Filed Nov 17, 2025 22:30 UTC
Tariq MusaDirector
Exercise / conversionRestricted Stock Units · Derivative 250 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001968281-25-000009 · wk-form4_1763418625.xml · derivative · entry 2

Tariq Musa · CIK 0001968281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,998

Underlying: Common Stock · 250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
November 15, 2025 Filed Nov 17, 2025 22:30 UTC
Tariq MusaDirector
Exercise / conversionCommon Stock 250 $0.00 $0.00
Disclosure

SEC source: 0001968281-25-000009 · wk-form4_1763418625.xml · nonDerivative · entry 1

Tariq Musa · CIK 0001968281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,975

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2025 Filed Nov 11, 2025 00:18 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $32.55 $0.00
Disclosure

SEC source: 0001865525-25-000011 · wk-form4_1762820291.xml · derivative · entry 4

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,029

Underlying: Common Stock · 1,000 shares

Expires 2034-07-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024, and the remaining 75% vests monthly for the three-year period thereafter.

Read SEC document
November 07, 2025 Filed Nov 11, 2025 00:18 UTC SaleCommon Stock 500 $95.23 $47,615.05
Disclosure

SEC source: 0001865525-25-000011 · wk-form4_1762820291.xml · nonDerivative · entry 3

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 815

Read SEC document
November 07, 2025 Filed Nov 11, 2025 00:18 UTC SaleCommon Stock 1,000 $95.17 $95,165.10
Disclosure

SEC source: 0001865525-25-000011 · wk-form4_1762820291.xml · nonDerivative · entry 2

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,315

Read SEC document
November 07, 2025 Filed Nov 11, 2025 00:18 UTC Exercise / conversionCommon Stock 1,000 $32.55 $32,550.00
Disclosure

SEC source: 0001865525-25-000011 · wk-form4_1762820291.xml · nonDerivative · entry 1

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2025 Filed Nov 11, 2025 00:17 UTC
Saia John G.Chief Legal Officer
SaleCommon Stock 8,996 $96.25 $865,865.00
Disclosure

SEC source: 0001737840-25-000009 · wk-form4_1762820259.xml · nonDerivative · entry 1

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,172

Read SEC document
October 31, 2025 Filed Nov 3, 2025 22:45 UTC Exercise / conversionRestricted Stock Units · Derivative 154 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001666236-25-000011 · wk-form4_1762209933.xml · derivative · entry 2

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,235

Underlying: Common Stock · 154 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This represents a restricted stock unit award granted on August 9, 2022 that vested as to 25% of the shares subject to such award on June 30, 2023. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of June 30, 2023 during the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 22:45 UTC Exercise / conversionCommon Stock 154 $0.00 $0.00
Disclosure

SEC source: 0001666236-25-000011 · wk-form4_1762209933.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 21, 2025 Filed Oct 22, 2025 23:07 UTC Exercise / conversionRestricted Stock Units · Derivative 3,167 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001258394-25-000006 · wk-form4_1761174473.xml · derivative · entry 2

MIGNONE ROBERTO · CIK 0001258394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,504

Underlying: Common Stock · 3,167 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024, and the remaining 75% vests monthly over the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 21, 2025 Filed Oct 22, 2025 23:07 UTC Exercise / conversionCommon Stock 3,167 $0.00 $0.00
Disclosure

SEC source: 0001258394-25-000006 · wk-form4_1761174473.xml · nonDerivative · entry 1

MIGNONE ROBERTO · CIK 0001258394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,167

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2025 Filed Oct 20, 2025 23:49 UTC
Tariq MusaDirector
SaleCommon Stock 116 $66.95 $7,766.20
Disclosure

SEC source: 0001968281-25-000008 · wk-form4_1761004181.xml · nonDerivative · entry 1

Tariq Musa · CIK 0001968281 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,725

Read SEC document
October 17, 2025 Filed Oct 20, 2025 23:50 UTC Exercise / conversionRestricted Stock Units · Derivative 232 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001865525-25-000009 · wk-form4_1761004237.xml · derivative · entry 2

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,657

Underlying: Common Stock · 232 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024. The remaining 75% vests monthly for the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 17, 2025 Filed Oct 20, 2025 23:50 UTC Exercise / conversionCommon Stock 232 $0.00 $0.00
Disclosure

SEC source: 0001865525-25-000009 · wk-form4_1761004237.xml · nonDerivative · entry 1

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2025 Filed Oct 20, 2025 23:48 UTC SaleCommon Stock 26 $66.95 $1,740.70
Disclosure

SEC source: 0001214130-25-000009 · wk-form4_1761004125.xml · nonDerivative · entry 1

POTTER MYRTLE S · CIK 0001214130 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,324

Read SEC document
October 15, 2025 Filed Oct 17, 2025 01:13 UTC
Tariq MusaDirector
Exercise / conversionRestricted Stock Units · Derivative 250 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001968281-25-000006 · wk-form4_1760663600.xml · derivative · entry 2

Tariq Musa · CIK 0001968281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,248

Underlying: Common Stock · 250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 01:13 UTC
Tariq MusaDirector
Exercise / conversionCommon Stock 250 $0.00 $0.00
Disclosure

SEC source: 0001968281-25-000006 · wk-form4_1760663600.xml · nonDerivative · entry 1

Tariq Musa · CIK 0001968281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,841

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 01:11 UTC Exercise / conversionRestricted Stock Units · Derivative 69 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001214130-25-000007 · wk-form4_1760663477.xml · derivative · entry 2

POTTER MYRTLE S · CIK 0001214130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 69 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on October 15, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of October 15, 2022, during the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 01:11 UTC Exercise / conversionCommon Stock 69 $0.00 $0.00
Disclosure

SEC source: 0001214130-25-000007 · wk-form4_1760663477.xml · nonDerivative · entry 1

POTTER MYRTLE S · CIK 0001214130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 9,954 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001871615-25-000006 · wk-form4_1759449909.xml · derivative · entry 7

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,210

Underlying: Common Stock · 9,954 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,668 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001871615-25-000006 · wk-form4_1759449909.xml · derivative · entry 6

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,669

Underlying: Common Stock · 1,668 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,928 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001871615-25-000006 · wk-form4_1759449909.xml · derivative · entry 5

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,714

Underlying: Common Stock · 1,928 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Freeman ChrisChief Commercial Officer
Tax withholdingCommon Stock 5,740 $62.65 $359,611.00
Disclosure

SEC source: 0001871615-25-000006 · wk-form4_1759449909.xml · nonDerivative · entry 4

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,439

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionCommon Stock 9,954 $0.00 $0.00
Disclosure

SEC source: 0001871615-25-000006 · wk-form4_1759449909.xml · nonDerivative · entry 3

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionCommon Stock 1,668 $0.00 $0.00
Disclosure

SEC source: 0001871615-25-000006 · wk-form4_1759449909.xml · nonDerivative · entry 2

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionCommon Stock 1,928 $0.00 $0.00
Disclosure

SEC source: 0001871615-25-000006 · wk-form4_1759449909.xml · nonDerivative · entry 1

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,557

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:03 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 23,997 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001753159-25-000004 · wk-form4_1759449830.xml · derivative · entry 6

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,986

Underlying: Common Stock · 23,997 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two year period.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:03 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
Tax withholdingCommon Stock 12,162 $62.65 $761,949.30
Disclosure

SEC source: 0001753159-25-000004 · wk-form4_1759449830.xml · nonDerivative · entry 4

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,997,874

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:03 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
Exercise / conversionCommon Stock 23,997 $0.00 $0.00
Disclosure

SEC source: 0001753159-25-000004 · wk-form4_1759449830.xml · nonDerivative · entry 3

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,010,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:06 UTC
Saia John G.Chief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 11,525 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001737840-25-000007 · wk-form4_1759449974.xml · derivative · entry 7

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,401

Underlying: Common Stock · 11,525 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:06 UTC
Saia John G.Chief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 1,668 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001737840-25-000007 · wk-form4_1759449974.xml · derivative · entry 6

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,669

Underlying: Common Stock · 1,668 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:06 UTC
Saia John G.Chief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 974 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001737840-25-000007 · wk-form4_1759449974.xml · derivative · entry 5

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,896

Underlying: Common Stock · 974 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:06 UTC
Saia John G.Chief Legal Officer
Tax withholdingCommon Stock 7,431 $62.65 $465,552.15
Disclosure

SEC source: 0001737840-25-000007 · wk-form4_1759449974.xml · nonDerivative · entry 4

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,168

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:06 UTC
Saia John G.Chief Legal Officer
Exercise / conversionCommon Stock 11,525 $0.00 $0.00
Disclosure

SEC source: 0001737840-25-000007 · wk-form4_1759449974.xml · nonDerivative · entry 3

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:06 UTC
Saia John G.Chief Legal Officer
Exercise / conversionCommon Stock 1,668 $0.00 $0.00
Disclosure

SEC source: 0001737840-25-000007 · wk-form4_1759449974.xml · nonDerivative · entry 2

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:06 UTC
Saia John G.Chief Legal Officer
Exercise / conversionCommon Stock 974 $0.00 $0.00
Disclosure

SEC source: 0001737840-25-000007 · wk-form4_1759449974.xml · nonDerivative · entry 1

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,406

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Monroe Terilyn J.Chief People Officer
Exercise / conversionRestricted Stock Units · Derivative 10,477 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001652956-25-000003 · wk-form4_1759449950.xml · derivative · entry 3

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,274

Underlying: Common Stock · 10,477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Monroe Terilyn J.Chief People Officer
Tax withholdingCommon Stock 5,310 $62.65 $332,671.50
Disclosure

SEC source: 0001652956-25-000003 · wk-form4_1759449950.xml · nonDerivative · entry 2

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,087

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Monroe Terilyn J.Chief People Officer
Exercise / conversionCommon Stock 10,477 $0.00 $0.00
Disclosure

SEC source: 0001652956-25-000003 · wk-form4_1759449950.xml · nonDerivative · entry 1

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,397

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:04 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 10,477 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562135-25-000006 · wk-form4_1759449889.xml · derivative · entry 7

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,274

Underlying: Common Stock · 10,477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:04 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,668 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562135-25-000006 · wk-form4_1759449889.xml · derivative · entry 6

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,669

Underlying: Common Stock · 1,668 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:04 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,714 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562135-25-000006 · wk-form4_1759449889.xml · derivative · entry 5

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,857

Underlying: Common Stock · 1,714 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:04 UTC
EAGLE CRAIGChief Medical Officer
Tax withholdingCommon Stock 7,025 $62.65 $440,116.25
Disclosure

SEC source: 0001562135-25-000006 · wk-form4_1759449889.xml · nonDerivative · entry 4

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,316

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:04 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionCommon Stock 10,477 $0.00 $0.00
Disclosure

SEC source: 0001562135-25-000006 · wk-form4_1759449889.xml · nonDerivative · entry 3

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:04 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionCommon Stock 1,668 $0.00 $0.00
Disclosure

SEC source: 0001562135-25-000006 · wk-form4_1759449889.xml · nonDerivative · entry 2

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:04 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionCommon Stock 1,714 $0.00 $0.00
Disclosure

SEC source: 0001562135-25-000006 · wk-form4_1759449889.xml · nonDerivative · entry 1

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,196

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Kalia KumudChief Information Officer
Exercise / conversionRestricted Stock Units · Derivative 7,858 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · derivative · entry 7

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,956

Underlying: Common Stock · 7,858 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 00:05 UTC
Kalia KumudChief Information Officer
Exercise / conversionRestricted Stock Units · Derivative 1,084 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001927831-25-000008 · wk-form4_1759449929.xml · derivative · entry 6

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,335

Underlying: Common Stock · 1,084 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.